Your browser doesn't support javascript.
loading
Multi-omic molecular profiling guide's efficacious treatment selection in refractory metastatic breast cancer: a prospective phase II clinical trial.
Pierobon, Mariaelena; Robert, Nicholas J; Northfelt, Donald W; Jahanzeb, Mohammad; Wong, Shukmei; Hodge, Kimberly A; Baldelli, Elisa; Aldrich, Jessica; Craig, David W; Liotta, Lance A; Avramovic, Sanja; Wojtusiak, Janusz; Alemi, Farrokh; Wulfkuhle, Julia D; Bellos, Angela; Gallagher, Rosa I; Arguello, David; Conrad, Amber; Kemkes, Ariane; Loesch, David M; Vocila, Linda; Dunetz, Bryant; Carpten, John D; Petricoin, Emanuel F; Anthony, Stephen P.
Afiliação
  • Pierobon M; George Mason University, Manassas, VA, USA.
  • Robert NJ; US Oncology Network/Virginia Cancer Specialists, Fairfax, VA, USA.
  • Northfelt DW; Mayo Clinic Arizona, Scottsdale, AZ, USA.
  • Jahanzeb M; A Division of 21st Century Oncology, Florida Precision Oncology, Raton, FL, USA.
  • Wong S; Translational Genomics Research Institute, Phoenix, AZ, USA.
  • Hodge KA; George Mason University, Manassas, VA, USA.
  • Baldelli E; George Mason University, Manassas, VA, USA.
  • Aldrich J; Translational Genomics Research Institute, Phoenix, AZ, USA.
  • Craig DW; Translational Genomics Research Institute, Phoenix, AZ, USA.
  • Liotta LA; George Mason University, Manassas, VA, USA.
  • Avramovic S; Department of Health Administration and Policy, George Mason University, Fairfax, VA, USA.
  • Wojtusiak J; Department of Health Administration and Policy, George Mason University, Fairfax, VA, USA.
  • Alemi F; Department of Health Administration and Policy, George Mason University, Fairfax, VA, USA.
  • Wulfkuhle JD; George Mason University, Manassas, VA, USA.
  • Bellos A; George Mason University, Manassas, VA, USA.
  • Gallagher RI; George Mason University, Manassas, VA, USA.
  • Arguello D; Caris Life Sciences, Phoenix, AZ, USA.
  • Conrad A; Caris Life Sciences, Phoenix, AZ, USA.
  • Kemkes A; Paradigm Diagnostics, Phoenix, AZ, USA.
  • Loesch DM; Paradigm Diagnostics, Phoenix, AZ, USA.
  • Vocila L; Translational Drug Development (TD2), Scottsdale, AZ, USA.
  • Dunetz B; The Side-Out Foundation, Fairfax, VA, USA.
  • Carpten JD; Translational Genomics Research Institute, Phoenix, AZ, USA.
  • Petricoin EF; George Mason University, Manassas, VA, USA.
  • Anthony SP; Evergreen Hematology-Oncology, Spokane, WA, USA.
Mol Oncol ; 16(1): 104-115, 2022 01.
Article em En | MEDLINE | ID: mdl-34437759
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Tipo de estudo: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Revista: Mol Oncol Assunto da revista: BIOLOGIA MOLECULAR / NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Tipo de estudo: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Revista: Mol Oncol Assunto da revista: BIOLOGIA MOLECULAR / NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos